Gods.com,Inc. — SEC Form D Filing

Gods.com,Inc. filed an SEC Form D on June 10, 2026, reporting $385K raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
June 10, 2026
Amount reported
$385K
Round stage
Seed
Industry
Health Technology
Website
https://gods.com/

What the company does

Securities: Equity. Exemption: Rule 506(c). Incorporated: DELAWARE

Problem

Consumers face uncertainty because many health products and supplements are not scientifically validated, may contain ineffective ingredients, and often do not address the complexities of how the body works.

Solution

Gods.com uses the CytoSolve® computational systems biology engine to analyze the active ingredients of supplements and health products at a molecular level, mapping their effects on biological pathways to predict real health outcomes and provide computational ratings for effectiveness.

Why now

There is a growing demand for scientifically validated health products as consumers become more health-conscious and skeptical of marketing claims.

Verdict

Investors backed Gods.com because it aligned with a rising consumer demand for scientifically validated health products, not merely due to the novelty of its CytoSolve technology. They implicitly bet on the narrative that consumers would prefer rigorous, data-driven health solutions over traditional marketing. However, the limited upside hinges on distinguishing itself amidst rapid market shifts, where many similar claims lack durability without robust, continuous validation.

Source: SEC EDGAR Form D filing